© 1992 British Society for Rheumatology
other |
CARTILAGE OLIGOMERIC MATRIX PROTEIN: A NOVEL MARKER OF CARTILAGE TURNOVER DETECTABLE IN SYNOVIAL FLUID AND BLOOD
*Department of Rheumatology, Lund University Hospital Lund, Sweden
Department of Physiological Chemistry, Lund University Lund, Sweden
Correspondence to:
Correspondence to T. Saxne, Department of Rheumatology, Lund University Hospital, S-221 85 Lund, Sweden
Cartilage oligomeric matrix protein (COMP) is a tissue specific non-collagenous matrix protein. We have developed an enzyme-linked immunosorbent assay for the detection of this protein in synovial fluid and serum. The protein has been quantified in these fluids in patients with rheumatoid arthritis (RA), reactive arthritis, juvenile chronic arthritis, osteoarthritis and in sera of control subjects. The protein was detectable in all fluids and the synovial fluid levels were always higher than in serum in paired samples. The highest knee joint synovial fluid levels were found in reactive arthritis patients and the lowest in RA patients with advanced destruction of the knee joint. However, the relative synovial fluid content of COMP was higher in these RA patients than in patients with advanced osteoarthritis. In patients with longstanding reactive synovitis the concentrations decreased. This decrease, however, was less marked than for proteoglycan concentrations.
The serum concentrations were low in patients with juvenile chronic arthritis and in patients with RA with advanced cartilage destruction of the studied knee joint. In the other groups serum levels did not differ between groups or from controls.
KEY WORDS: Cartilage matrix, Noncollagenous protein, Rheumatoid arthritis, Proteoglycans
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R Hesselstrand, A Kassner, D Heinegard, and T Saxne COMP: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker Ann Rheum Dis, September 1, 2008; 67(9): 1242 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Gagarina, A. L. Carlberg, L. Pereira-Mouries, and D. J. Hall Cartilage Oligomeric Matrix Protein Protects Cells against Death by Elevating Members of the IAP Family of Survival Proteins J. Biol. Chem., January 4, 2008; 283(1): 648 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yamamoto, H. Takahashi, C. Suzuki, Y. Naishiro, H. Yamamoto, K. Imai, and Y. Shinomura Cartilage oligomeric matrix protein in systemic sclerosis Rheumatology, December 1, 2007; 46(12): 1858 - 1859. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hultqvist, J. Backlund, K. Bauer, K. A. Gelderman, and R. Holmdahl Lack of Reactive Oxygen Species Breaks T Cell Tolerance to Collagen Type II and Allows Development of Arthritis in Mice J. Immunol., August 1, 2007; 179(3): 1431 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Xu, Y. Zhang, K. Ilalov, C. S. Carlson, J. Q. Feng, P. E. Di Cesare, and C.-j. Liu Cartilage Oligomeric Matrix Protein Associates with Granulin-Epithelin Precursor (GEP) and Potentiates GEP-stimulated Chondrocyte Proliferation J. Biol. Chem., April 13, 2007; 282(15): 11347 - 11355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M L E Andersson, I F Petersson, K E Karlsson, E N Jonsson, B Mansson, D Heinegard, and T Saxne Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis Ann Rheum Dis, November 1, 2006; 65(11): 1490 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Medicherla, J. Y. Ma, R. Mangadu, Y. Jiang, J. J. Zhao, R. Almirez, I. Kerr, E. G. Stebbins, G. O'Young, A. M. Kapoun, et al. A Selective p38{alpha} Mitogen-Activated Protein Kinase Inhibitor Reverses Cartilage and Bone Destruction in Mice with Collagen-Induced Arthritis J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 132 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-j. Liu, W. Kong, K. Xu, Y. Luan, K. Ilalov, B. Sehgal, S. Yu, R. D. Howell, and P. E. Di Cesare ADAMTS-12 Associates with and Degrades Cartilage Oligomeric Matrix Protein J. Biol. Chem., June 9, 2006; 281(23): 15800 - 15808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-j. Liu, W. Kong, K. Ilalov, S. Yu, K. Xu, L. Prazak, M. Fajardo, B. Sehgal, and P. E. Di Cesare ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein FASEB J, May 1, 2006; 20(7): 988 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sharif, R. Granell, J. Johansen, S. Clarke, C. Elson, and J. R. Kirwan Serum cartilage oligomeric matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee Rheumatology, May 1, 2006; 45(5): 522 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bileviciute-Ljungar, T. Saxne, and M. Spetea Anti-inflammatory effects of contralateral administration of the {kappa}-opioid agonist U-50,488H in rats with unilaterally induced adjuvant arthritis Rheumatology, March 1, 2006; 45(3): 295 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Weitoft, A Larsson, T Saxne, and L Ronnblom Changes of cartilage and bone markers after intra-articular glucocorticoid treatment with and without postinjection rest in patients with rheumatoid arthritis Ann Rheum Dis, December 1, 2005; 64(12): 1750 - 1753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Senolt, M Braun, M Olejarova, S Forejtova, J Gatterova, and K Pavelka Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein Ann Rheum Dis, June 1, 2005; 64(6): 886 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Lindqvist, K Eberhardt, K Bendtzen, D Heinegard, and T Saxne Prognostic laboratory markers of joint damage in rheumatoid arthritis Ann Rheum Dis, February 1, 2005; 64(2): 196 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bjarnason, B. Andersson, H. S. Kim, B. Olsson, D. Swolin-Eide, R. Wickelgren, B. Kristrom, B. Carlsson, K. Albertsson-Wikland, L. M. S. Carlsson, et al. Cartilage Oligomeric Matrix Protein Increases in Serum after the Start of Growth Hormone Treatment in Prepubertal Children J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5156 - 5160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hultqvist, P. Olofsson, J. Holmberg, B. T. Backstrom, J. Tordsson, and R. Holmdahl Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene PNAS, August 24, 2004; 101(34): 12646 - 12651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Larsson, H. Erlandsson Harris, A. Larsson, B. Mansson, T. Saxne, and L. Klareskog Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP Rheumatology, April 1, 2004; 43(4): 428 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F A Wollheim Early stages of osteoarthritis: the search for sensitive predictors Ann Rheum Dis, November 1, 2003; 62(11): 1031 - 1032. [Full Text] [PDF]
|
|
|
|
|
|
P. Olofsson, J. Holmberg, U. Pettersson, and R. Holmdahl Identification and Isolation of Dominant Susceptibility Loci for Pristane-Induced Arthritis J. Immunol., July 1, 2003; 171(1): 407 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H Forsblad d'Elia, A Larsen, E Waltbrand, G Kvist, D Mellstrom, T Saxne, C Ohlsson, E Nordborg, and H Carlsten Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis Ann Rheum Dis, July 1, 2003; 62(7): 617 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Saxne, M. Lindell, B. Mansson, I. F. Petersson, and D. Heinegard Inflammation is a feature of the disease process in early knee joint osteoarthritis Rheumatology, July 1, 2003; 42(7): 903 - 905. [Full Text] [PDF]
|
|
|
|
|
|
E Murphy, O FitzGerald, T Saxne, and B Bresnihan Increased serum cartilage oligomeric matrix protein levels and decreased patellar bone mineral density in patients with chondromalacia patellae Ann Rheum Dis, November 1, 2002; 61(11): 981 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Larsson, H. Erlandsson Harris, J. C. Lorentzen, A. Larsson, B. Mansson, L. Klareskog, and T. Saxne Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats Rheumatology, September 1, 2002; 41(9): 996 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Swan, H Amer, and P Dieppe The value of synovial fluid assays in the diagnosis of joint disease: a literature survey Ann Rheum Dis, June 1, 2002; 61(6): 493 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A A den Broeder, L A B Joosten, T Saxne, D Heinegard, H Fenner, A M M Miltenburg, W L H Frasa, L J van Tits, W A Buurman, P L C M van Riel, et al. Long term anti-tumour necrosis factor {alpha} monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation Ann Rheum Dis, April 1, 2002; 61(4): 311 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Roux-Lombard, K. Eberhardt, T. Saxne, J.-M. Dayer, and F. A. Wollheim Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study Rheumatology, May 1, 2001; 40(5): 544 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Månsson, A Gülfe, P Geborek, D Heinegård, and T Saxne Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis Ann Rheum Dis, January 1, 2001; 60(1): 27 - 31. [Abstract] [Full Text]
|
|
|
|
|
|
L. A. B. Joosten, M. M. A. Helsen, T. Saxne, F. A. J. van de Loo, and W. B. van den Berg IL-1{alpha}{beta} Blockade Prevents Cartilage and Bone Destruction in Murine Type II Collagen-Induced Arthritis, Whereas TNF-{alpha} Blockade Only Ameliorates Joint Inflammation J. Immunol., November 1, 1999; 163(9): 5049 - 5055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Conrozier, T. Saxne, C. S. S. Fan, P. Mathieu, A.-M. Tron, D. Heinegård, and E. Vignon Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: A one year prospective study Ann Rheum Dis, September 1, 1998; 57(9): 527 - 532. [Abstract] [Full Text]
|
|
|
|
|
|
E. Lindqvist and T. Saxne Cartilage macromolecules in knee joint synovial fluid. Markers of the disease course in patients with acute oligoarthritis Ann Rheum Dis, December 1, 1997; 56(12): 751 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. BUCKWALTER and H. J. MANKIN Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Articular Cartilage. Part I: Tissue Design and Chondrocyte-Matrix Interactions*{{dagger}} J. Bone Joint Surg. Am., April 1, 1997; 79(4): 600 - 11. [Full Text]
|
|
|
|
|
|
B. Månsson, P. Geborek, and T. Saxne Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: relation to development of knee or hip joint destruction Ann Rheum Dis, February 1, 1997; 56(2): 91 - 96. [Abstract] [Full Text]
|
|
|
|
|
|
I. F Petersson, L. Sandqvist, B. Svensson, and T. Saxne Cartilage markers in synovial fluid in symptomatic knee osteoarthritis Ann Rheum Dis, January 1, 1997; 56(1): 64 - 67. [Abstract] [Full Text]
|
|
|
|
|
|
J. Thur, K. Rosenberg, D. P. Nitsche, T. Pihlajamaa, L. Ala-Kokko, D. Heinegard, M. Paulsson, and P. Maurer Mutations in Cartilage Oligomeric Matrix Protein Causing Pseudoachondroplasia and Multiple Epiphyseal Dysplasia Affect Binding of Calcium and Collagen I, II, and IX J. Biol. Chem., February 23, 2001; 276(9): 6083 - 6092. [Abstract] [Full Text] [PDF]
|
|